Abstract
Cultures of a mouse cell line (PAM) were treated with 71 multiple sclerosis (MS) and 45 non-MS samples. Of the cultures treated with MS material, 80 percent (58) showed a reduction in cell yield (compared to untreated controls) of at least 20 percent by the third passage after inoculation. The MS samples were from 40 MS cases, and a total of 36 cases yielded at least one positive sample. The agent responsible for the decrease was not limited to nervous tissue, but was also found in serum, cerebrospinal fluid, spleen, kidney, and lymph node of MS patients. Positive samples were present at every stage of the disease. None of the non-MS samples yielded cell counts significantly different from untreated controls. The non-MS category included 12 samples from healthy individuals, 13 assorted non-central nervous system disease samples, and the following central nervous system disease samples: six subacute sclerosing panencephalitis, three Huntington's chorea, two Parkinsonism, six amyotrophic lateral sclerosis, one stroke, one encephalopathy, and one epilepsy. Brain homogenates from mice inoculated with MS tissues elicited the decrease, whereas brain homogenates from mice inoculated with non-MS samples did not.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADAMS J. M., IMAGAWA D. T. Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med. 1962 Dec;111:562–566. doi: 10.3181/00379727-111-27855. [DOI] [PubMed] [Google Scholar]
- Barbosa L. H., Hamilton R. Virological studies with multiple-sclerosis brain tissues. Lancet. 1973 Jun 23;1(7817):1415–1417. doi: 10.1016/s0140-6736(73)91741-8. [DOI] [PubMed] [Google Scholar]
- Carp R. I., Merz G. S., Licursi P. C. Reduced cell yields of mouse cell line cultures after exposure to homogenates of multiple sclerosis tissues. Infect Immun. 1974 Jun;9(6):1011–1015. doi: 10.1128/iai.9.6.1011-1015.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Field E. J., Cowshall S., Narang H. K., Bell T. M. Viruses in multiple sclerosis? Lancet. 1972 Aug 5;2(7771):280–281. doi: 10.1016/s0140-6736(72)91714-x. [DOI] [PubMed] [Google Scholar]
- Hayflick L. Tissue cultures and mycoplasmas. Tex Rep Biol Med. 1965 Jun;23(Suppl):285+–285+. [PubMed] [Google Scholar]
- Henson T. E., Brody J. A., Sever J. L., Dyken M. L., Cannon J. Measles antibody titers in multiple sclerosis patients, siblings, and controls. JAMA. 1970 Mar 23;211(12):1985–1988. [PubMed] [Google Scholar]
- Kempe C. H., Takabayashi K., Miyamoto H., McIntosh K., Tourtellotte W. W., Adams J. M. Elevated cerebrospinal fluid vaccinia antibodies in multiple sclerosis. Arch Neurol. 1973 Apr;28(4):278–279. doi: 10.1001/archneur.1973.00490220086016. [DOI] [PubMed] [Google Scholar]
- Miller H. Epidemiological aspects of multiple sclerosis. Proc R Soc Med. 1968 Sep;61(9):937–940. [PMC free article] [PubMed] [Google Scholar]
- Narang H. K., Field E. J. Paramyxovirus like tubules in multiple sclerosis biopsy material. Acta Neuropathol. 1973;25(4):281–290. doi: 10.1007/BF00691756. [DOI] [PubMed] [Google Scholar]
- Prineas J. Paramyxovirus-like particles associated with acute demyelination in chronic relapsing multiple sclerosis. Science. 1972 Nov 17;178(4062):760–763. doi: 10.1126/science.178.4062.760. [DOI] [PubMed] [Google Scholar]
- Tourtellotte W. On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system. J Neurol Sci. 1970 Mar;10(3):279–304. doi: 10.1016/0022-510x(70)90156-5. [DOI] [PubMed] [Google Scholar]